Evolent Health (EVH) Competitors $10.44 -0.27 (-2.51%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$10.58 +0.13 (+1.28%) As of 02/21/2025 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends EVH vs. FTDR, CARG, DLO, TNET, PAYO, DXC, ALIT, ATHM, ACVA, and CLVTShould you be buying Evolent Health stock or one of its competitors? The main competitors of Evolent Health include Frontdoor (FTDR), CarGurus (CARG), DLocal (DLO), TriNet Group (TNET), Payoneer Global (PAYO), DXC Technology (DXC), Alight (ALIT), Autohome (ATHM), ACV Auctions (ACVA), and Clarivate (CLVT). These companies are all part of the "business services" industry. Evolent Health vs. Frontdoor CarGurus DLocal TriNet Group Payoneer Global DXC Technology Alight Autohome ACV Auctions Clarivate Evolent Health (NYSE:EVH) and Frontdoor (NASDAQ:FTDR) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, community ranking, analyst recommendations, earnings, risk, profitability and media sentiment. Does the media prefer EVH or FTDR? In the previous week, Evolent Health had 20 more articles in the media than Frontdoor. MarketBeat recorded 25 mentions for Evolent Health and 5 mentions for Frontdoor. Frontdoor's average media sentiment score of 0.59 beat Evolent Health's score of 0.33 indicating that Frontdoor is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Evolent Health 4 Very Positive mention(s) 3 Positive mention(s) 10 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral Frontdoor 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, EVH or FTDR? Frontdoor has lower revenue, but higher earnings than Evolent Health. Evolent Health is trading at a lower price-to-earnings ratio than Frontdoor, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEvolent Health$1.96B0.62-$113.04M-$0.91-11.47Frontdoor$1.78B2.43$171M$3.0218.91 Do analysts rate EVH or FTDR? Evolent Health presently has a consensus price target of $17.79, indicating a potential upside of 70.34%. Frontdoor has a consensus price target of $51.75, indicating a potential downside of 9.37%. Given Evolent Health's stronger consensus rating and higher probable upside, equities analysts clearly believe Evolent Health is more favorable than Frontdoor.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Evolent Health 0 Sell rating(s) 1 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 3.00Frontdoor 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Which has more volatility & risk, EVH or FTDR? Evolent Health has a beta of 1.45, indicating that its share price is 45% more volatile than the S&P 500. Comparatively, Frontdoor has a beta of 1.08, indicating that its share price is 8% more volatile than the S&P 500. Does the MarketBeat Community favor EVH or FTDR? Evolent Health received 437 more outperform votes than Frontdoor when rated by MarketBeat users. Likewise, 74.74% of users gave Evolent Health an outperform vote while only 58.80% of users gave Frontdoor an outperform vote. CompanyUnderperformOutperformEvolent HealthOutperform Votes57474.74% Underperform Votes19425.26% FrontdoorOutperform Votes13758.80% Underperform Votes9641.20% Is EVH or FTDR more profitable? Frontdoor has a net margin of 12.87% compared to Evolent Health's net margin of -2.93%. Frontdoor's return on equity of 132.99% beat Evolent Health's return on equity.Company Net Margins Return on Equity Return on Assets Evolent Health-2.93% 6.30% 2.57% Frontdoor 12.87%132.99%22.10% SummaryEvolent Health beats Frontdoor on 9 of the 17 factors compared between the two stocks. Get Evolent Health News Delivered to You Automatically Sign up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EVH vs. The Competition Export to ExcelMetricEvolent HealthManagement services IndustryComputer SectorNYSE ExchangeMarket Cap$1.22B$6.53B$26.22B$20.07BDividend YieldN/A3.54%2.74%3.65%P/E Ratio-11.4710.5646.3434.90Price / Sales0.621.722,532.9615.64Price / Cash5.8912.4735.5720.85Price / Book1.117.546.864.92Net Income-$113.04M$208.00M$731.18M$1.02B7 Day Performance3.74%-0.26%-2.05%-1.05%1 Month Performance4.46%-3.48%-0.12%-1.09%1 Year Performance-64.95%-22.91%19.96%13.70% Evolent Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EVHEvolent Health2.6172 of 5 stars$10.44-2.5%$17.79+70.3%-65.1%$1.22B$1.96B-11.474,700Earnings ReportAnalyst ForecastNews CoverageHigh Trading VolumeFTDRFrontdoor2.8823 of 5 stars$59.46+1.0%$51.75-13.0%+75.5%$4.51B$1.78B19.691,716CARGCarGurus3.5984 of 5 stars$39.77-0.9%$38.41-3.4%+36.0%$4.12B$914.24M-86.451,343Earnings ReportAnalyst ForecastShort Interest ↓News CoverageGap DownDLODLocal2.1724 of 5 stars$13.39+2.2%$11.81-11.8%-21.0%$3.96B$729.49M33.48540News CoverageTNETTriNet Group3.8656 of 5 stars$77.35-1.4%$115.67+49.5%-46.0%$3.84B$4.92B14.903,600Analyst DowngradeHigh Trading VolumePAYOPayoneer Global3.7826 of 5 stars$10.56+0.8%$12.00+13.6%+84.8%$3.77B$940.30M30.172,167Upcoming EarningsNews CoverageDXCDXC Technology1.9768 of 5 stars$20.35-1.1%$21.38+5.1%-3.9%$3.68B$13.67B-48.44130,000ALITAlight3.6957 of 5 stars$6.76+0.4%$10.61+57.1%-26.6%$3.67B$3.41B-14.0718,000Earnings ReportAnalyst ForecastNews CoverageATHMAutohome1.7721 of 5 stars$30.19+1.9%$28.00-7.2%+10.2%$3.66B$1.01B15.025,511Earnings ReportAnalyst DowngradeNews CoverageACVAACV Auctions3.7422 of 5 stars$21.59flat$23.65+9.5%+25.9%$3.62B$596.02M-45.942,170Earnings ReportAnalyst ForecastNews CoverageCLVTClarivate3.711 of 5 stars$4.91-0.7%$7.10+44.8%-45.3%$3.48B$2.63B-2.4612,000Analyst ForecastNews Coverage Related Companies and Tools Related Companies FTDR Alternatives CARG Alternatives DLO Alternatives TNET Alternatives PAYO Alternatives DXC Alternatives ALIT Alternatives ATHM Alternatives ACVA Alternatives CLVT Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:EVH) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredShocking Elon Move: Bigger than DOGE?After saving free speech with his acquisition of Twitter… And after blowing everyone’s minds with his recen...Brownstone Research | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolent Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evolent Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.